Psoriatic Arthritis and Psoriasis Treatment Decision Aid

Completed · Not applicable

Conditions studied: Psoriatic Arthritis, Psoriasis

In brief

The purpose of this study is to create and test a patient decision aid that facilitates the shared decision-making process when patients with psoriasis and/or psoriatic arthritis are starting or switching to a new therapy.

Key facts

Study ID

NCT03737045

Run by

University of Pennsylvania

People needed

37

Starts

2018-12-01

Expected to finish

2025-12-31

Last updated by the study team

2026-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or older
• Diagnosis of psoriasis (as confirmed by dermatologist) or psoriatic arthritis (as confirmed by rheumatologist)
• Treated at Penn
• In addition to the above, for the observation and implementation phases of the study:
• Initiation of a new psoriasis or psoriatic arthritis treatment
• Biosimilars that have been approved by the FDA and available on the US market will similarly be eligible for participation
• Patients may be taking other traditional DMARDs.
• A washout period is not required.

You may not qualify if…

• Unable to give informed consent
• Youth, under the age of 18 years
• Patients without psoriasis or psoriatic arthritis
• Not being treated at a Penn clinic
• In addition to the above, for the observation and implementation phases of the study:
• Not starting or switching to a new medication

Where it is running

• Hospital at the University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.